Goodbody Health Limited
GDBYF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | -$0 | -$0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -15.6% | -56.8% | -28% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 44.9% | 45.4% | 50.4% | 50.5% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -44.6% | -39.4% | 4.2% | 3.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -67.1% | -51.3% | -5.1% | -14.6% |
| EPS Diluted | -0.035 | -0.031 | -0.007 | 0 |
| % Growth | -10.5% | -330.1% | – | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |